A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy. (posted Oct. 3, 2013)
Search results for: cardiovascular disease
Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis
Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases
Letters: The True Challenge of Rheumatology
A physician reflects on an emotional visit with a terminally ill patient
Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?
Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)
Letter: There’s No Reason Now to Screen for Uric Acid
Screening was common in the 1970s and before, but new studies demonstrate that most hyperuricemia patients never developed gout or kidney stones, so enthusiasm for screening waned
ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior
With teenaged juvenile arthritis patients, it’s important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them
Depression in Rheumatoid Arthritis
Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression
Treat to Target: Rheumatoid Arthritis in Pregnant Patients
A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women
ACR Releases Guidelines for Gout Management
The American College of Rheumatology’s two-part guidelines stress the need for treating to target, more aggressive management, and therapy
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 65
- Next Page »